Healthcare provider profile · identity verified

Timothy R Mcfarland, M.D.

Family Practice · CUERO, TX · NPI 1790789253

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Donepezil Hcl	Donepezil Hcl	586	50
Atorvastatin Calcium	Atorvastatin Calcium	496	58
Gabapentin	Gabapentin	455	38
Levothyroxine Sodium	Levothyroxine Sodium	419	37
Potassium Chloride	Potassium Chloride	417	44
Furosemide	Furosemide	332	41
Sertraline Hcl	Sertraline Hcl	323	26
Trazodone Hcl	Trazodone Hcl	321	37
Memantine Hcl	Memantine Hcl	305	35
Amlodipine Besylate	Amlodipine Besylate	301	34
Tamsulosin Hcl	Tamsulosin Hcl	261	27
Eliquis	Apixaban	246	23
Divalproex Sodium	Divalproex Sodium	243	33
Metoprolol Tartrate	Metoprolol Tartrate	220	29
Lisinopril	Lisinopril	199	25
Clopidogrel	Clopidogrel Bisulfate	174	20
Losartan Potassium	Losartan Potassium	162	19
Mirtazapine	Mirtazapine	157	22
Duloxetine Hcl	Duloxetine Hcl	155	19
Tramadol Hcl	Tramadol Hcl	155	23
Levetiracetam	Levetiracetam	154	13
Metoprolol Succinate	Metoprolol Succinate	148	19
Buspirone Hcl	Buspirone Hcl	136	19
Metformin Hcl	Metformin Hcl	133	13
Hydrochlorothiazide	Hydrochlorothiazide	116	suppressed
Clonazepam	Clonazepam	106	16
Xarelto	Rivaroxaban	93	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	91	12
Finasteride	Finasteride	85	suppressed
Oxcarbazepine	Oxcarbazepine	85	suppressed
Baclofen	Baclofen	82	suppressed
Carvedilol	Carvedilol	78	suppressed
Ondansetron Hcl	Ondansetron Hcl	76	21
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	72	34
Montelukast Sodium	Montelukast Sodium	72	suppressed
Simvastatin	Simvastatin	70	suppressed
Hydralazine Hcl	Hydralazine Hcl	67	suppressed
Myrbetriq	Mirabegron	67	suppressed
Alendronate Sodium	Alendronate Sodium	66	suppressed
Latanoprost	Latanoprost	66	11
Meloxicam	Meloxicam	66	suppressed
Cephalexin	Cephalexin	64	33
Spironolactone	Spironolactone	64	suppressed
Alprazolam	Alprazolam	63	15
Pantoprazole Sodium	Pantoprazole Sodium	63	15
Lorazepam	Lorazepam	61	17
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	56	14
Quetiapine Fumarate	Quetiapine Fumarate	56	suppressed
Allopurinol	Allopurinol	55	suppressed
Rivastigmine	Rivastigmine	54	suppressed
Divalproex Sodium Er	Divalproex Sodium	51	suppressed
Famotidine	Famotidine	51	14
Pravastatin Sodium	Pravastatin Sodium	50	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	50	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	48	suppressed
Glipizide	Glipizide	48	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	47	12
Lactulose	Lactulose	47	12
Calcium Acetate	Calcium Acetate	46	suppressed
Topiramate	Topiramate	43	suppressed
Januvia	Sitagliptin Phosphate	42	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	41	suppressed
Olanzapine	Olanzapine	39	suppressed
Citalopram Hbr	Citalopram Hydrobromide	38	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	38	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	37	12
Methocarbamol	Methocarbamol	37	suppressed
Cinacalcet Hcl	Cinacalcet Hcl	36	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	36	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	35	11
Sucralfate	Sucralfate	35	suppressed
Medroxyprogesterone Acetate	Medroxyprogesterone Acetate	32	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	32	suppressed
Entresto	Sacubitril/Valsartan	31	suppressed
Jardiance	Empagliflozin	31	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	30	suppressed
Atenolol	Atenolol	29	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	29	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	28	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	28	19
Oxybutynin Chloride Er	Oxybutynin Chloride	26	suppressed
Rivastigmine	Rivastigmine Tartrate	26	suppressed
Solifenacin Succinate	Solifenacin Succinate	26	suppressed
Anastrozole	Anastrozole	25	suppressed
Cilostazol	Cilostazol	25	suppressed
Jentadueto	Linagliptin/Metformin Hcl	25	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	25	suppressed
Phenytoin	Phenytoin	25	suppressed
Prednisone	Prednisone	25	11
Primidone	Primidone	25	suppressed
Diltiazem Hcl	Diltiazem Hcl	24	suppressed
Hydrocortisone	Hydrocortisone	24	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	24	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	23	suppressed
Farxiga	Dapagliflozin Propanediol	23	suppressed
Invega Sustenna	Paliperidone Palmitate	23	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	23	suppressed
Labetalol Hcl	Labetalol Hcl	23	suppressed
Lubiprostone	Lubiprostone	23	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	22	13
Enalapril Maleate	Enalapril Maleate	22	suppressed
Glycopyrrolate	Glycopyrrolate	22	suppressed
Ondansetron Odt	Ondansetron	22	16
Oseltamivir Phosphate	Oseltamivir Phosphate	22	14
Bicalutamide	Bicalutamide	21	suppressed
Breo Ellipta	Fluticasone/Vilanterol	21	suppressed
Bupropion Xl	Bupropion Hcl	21	suppressed
Temazepam	Temazepam	21	suppressed
Terazosin Hcl	Terazosin Hcl	21	suppressed
Valsartan	Valsartan	21	suppressed
Midodrine Hcl	Midodrine Hcl	20	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	20	20
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	20	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	19	suppressed
Multaq	Dronedarone Hcl	19	suppressed
Amiloride Hcl	Amiloride Hcl	18	suppressed
Calcitriol	Calcitriol	18	suppressed
Ceftriaxone	Ceftriaxone Sodium	18	11
Ciprofloxacin Hcl	Ciprofloxacin Hcl	18	13
Doxazosin Mesylate	Doxazosin Mesylate	18	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	18	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	18	suppressed
Omeprazole	Omeprazole	18	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	17	suppressed
Megestrol Acetate	Megestrol Acetate	17	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	17	suppressed
Propranolol Hcl	Propranolol Hcl	17	suppressed
Risperidone	Risperidone	17	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	16	suppressed
Digoxin	Digoxin	16	suppressed
Fenofibrate	Fenofibrate	16	suppressed
Fluticasone Propionate	Fluticasone Propionate	15	suppressed
Levofloxacin	Levofloxacin	15	12
Tizanidine Hcl	Tizanidine Hcl	15	suppressed
Bupropion Hcl Sr	Bupropion Hcl	14	suppressed
Fenofibrate	Fenofibrate,micronized	14	suppressed
Lidocaine Hcl	Lidocaine Hcl/Pf	14	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	14	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	14	suppressed
Propranolol Hcl Er	Propranolol Hcl	14	suppressed
Trulicity	Dulaglutide	14	suppressed
Ursodiol	Ursodiol	14	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	13	suppressed
Bumetanide	Bumetanide	13	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	13	suppressed
Lamotrigine	Lamotrigine	13	suppressed
Letrozole	Letrozole	13	suppressed
Lovastatin	Lovastatin	13	suppressed
Valproic Acid	Valproic Acid (As Sodium Salt)	13	suppressed
Benztropine Mesylate	Benztropine Mesylate	12	suppressed
Cholestyramine	Cholestyramine (With Sugar)	12	suppressed
Novolin 70-30 Flexpen	Insulin Nph Hum/Reg Insulin Hm	12	suppressed
Paroxetine Hcl	Paroxetine Hcl	12	suppressed
Ertapenem	Ertapenem Sodium	11	suppressed
Fluconazole	Fluconazole	11	suppressed
Glucagon Emergency Kit	Glucagon	11	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	11	suppressed
Sevelamer Carbonate	Sevelamer Carbonate	11	suppressed
Sevelamer Hcl	Sevelamer Hcl	11	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error